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ABSTRACT 21 
Context: It has been indicated that acute active and passive tobacco cigarette smoking may cause 22 
changes on redox status balance that may result in significant pathologies. However, no study has 23 
evaluated the effects of active and passive e-cigarette smoking on redox status of consumers.  24 
Objective: To examine the acute effects of active and passive e-cigarette and tobacco cigarette smoking 25 
on selected redox status markers. 26 
Methods: Using a randomized single-blind crossover design, 30 participants (15 smokers and 15 non-27 
smokers) were exposed to three different experimental conditions. Smokers underwent a control 28 
session, an active tobacco cigarette smoking session (smoked 2 cigarettes within 30-min) and an active 29 
e-cigarette smoking session (smoked a pre-determined number of puffs within 30-min using a liquid 30 
with 11 ng/ml nicotine). Similarly, non- smokers underwent a control session, a passive tobacco 31 
cigarette smoking session (exposure of 1 hour to 23±1 ppm of CO in a 60 m
3
 environmental chamber) 32 
and a passive e-cigarette smoking session (exposure of 1 hour to air enriched with pre- determined 33 
number of puffs in a 60 m
3
 environmental chamber). Total antioxidant capacity (TAC), catalase activity 34 
(CAT) and reduced glutathione (GSH) were assessed in participants’ blood prior to, immediately after, 35 
and 1-hour post-exposure. Results: TAC, CAT and GSH remained similar to baseline levels immediately 36 
after and 1-hour-post exposure (p>0.05) in all trials. Conclusions: Tobacco and e-cigarette smoking 37 
exposure do not acutely alter the response of the antioxidant system, neither under active nor passive 38 
smoking conditions. Overall, there is not distinction between tobacco an e-cigarette active and passive 39 
smoking effects on specific redox status indices.  40 
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INTRODUCTION 41 
During the past decade, a new product has been introduced in the tobacco smoking substitutes market, 42 
called electronic cigarette (e-cigarette) (Flouris and Oikonomou, 2010, Etter et al., 2011). The e-cigarette 43 
is an electronic nicotine delivery device which consists of a rechargeable battery, an evaporator and 44 
disposable filters (Flouris and Oikonomou, 2010, Etter et al., 2011). Due to lack of research on the safety 45 
of e-cigarettes, the World Health Organization called for intensified research assessing the health effects 46 
of e-cigarette use (World Health Organisation, 2010). Addressing this call, several studies have been 47 
recently conducted on e-cigarettes. Some of these studies showed that the levels of tobacco-specific 48 
toxicants in e-cigarette can be 9-450 times lower than in tobacco cigarette smoke (Goniewicz et al., 49 
2014), supporting the role of e-cigarettes in reducing harm from tobacco smoking. However, other 50 
studies report that e-cigarette ‘vaping’ introduces new dangers. For example, it has been reported that a 51 
high toxicity component, diethylene glycol, was detected in the liquid of e-cigarettes, albeit in 52 
“approved” levels (Varlet et al., 2015). Additionally, substances like polycyclic aromatic hydrocarbons 53 
and carcinogenic nitrosamines have been detected in some e-cigarette liquids (Pisinger and Dossing, 54 
2014). Overall, the presence of such toxic agents appears to be brand-specific, as researchers examining 55 
other brands found no traces of toxic or carcinogenic substances (Leondiadis, 2009). The above and 56 
other conflicting reports have prompted calls for effective regulation and promotion of e-cigarette as 57 
substitutes to tobacco smoking for existing smokers (Etter et al., 2011, Farsalinos and Le Houezec, 2015), 58 
especially given the appeal of e-cigarettes to adolescents (Dutra and Glantz, 2014). 59 
Oxidative stress reflects an imbalance between the systemic manifestation of free radicals and 60 
the biological system’s ability to detoxify these reactive intermediates or to repair the resulting damage 61 
(Sies and Cadenas, 1985). This redox imbalance may cause toxic effects that damage all components of 62 
the cell including proteins, lipids and nucleic acids. Thus, oxidative stress is thought to be involved in the 63 
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development of several diseases such as cancer, cardiovascular disease, Parkinson’s disease, Alzheimer’s 64 
disease and chronic fatigue syndrome (Sies and Cadenas, 1985). Reports indicate that the acute and long 65 
term (i.e., chronic) effects of active and passive tobacco cigarette smoking may attenuate the 66 
antioxidant defense system response which can, in turn, generate long-term pathologies (Valkonen and 67 
Kuusi, 1998, Scheffler et al., 1992). For example, increased lipid peroxidation and protein modification 68 
due to smoking has been reported extensively in the literature when smokers were compared to non-69 
smokers (Pignatelli et al., 2001, Petruzzelli et al., 1997). Even though the exact mechanism that links 70 
smoking with the development of atherosclerosis and damage to the vascular wall is still unclear, 71 
evidence suggests that oxidants delivered by the tar and the gas phase become deposited in the lung 72 
and also are delivered directly to the plasma and the vasculature and therefore activating enzymes 73 
responsible for pro-oxidant development in the vascular wall (Heitzer et al., 2000). Furthermore, 74 
damage to the vasculature can occur due to activation of neutrophils, monocytes, platelets, and T cells. 75 
In addition, endothelial dysfunction that is present in active and passive smokers is augmented by the 76 
antioxidant vitamin C, indicating that oxidative stress plays a crucial role in that phenomenon (Heitzer et 77 
al., 2000). 78 
Currently, the effects of active and passive e-cigarette smoking on redox status remain 79 
unknown. Evaluating the human redox status response to active and passive e-cigarette smoking may 80 
aid in the understanding of oxidative stress contribution to the development of smoking-related 81 
diseases. Therefore, the aim of this investigation was to examine the acute effects of active and passive 82 
e-cigarette and tobacco cigarette smoking on selected redox status markers. Based on the 83 
aforementioned findings that e-cigarettes may generate a reduced disruption in different body systems, 84 
it was hypothesized that the acute effects of active and passive e-cigarette smoking on redox status 85 
would be less pronounced as compared to active and passive tobacco cigarette smoking. 86 
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 87 
MATERIALS AND METHODS 88 
Participants 89 
The experimental protocol was approved by the Ethics Committee of the Department of Physical 90 
Education and Sports Science at the University of Thessaly. Two groups of healthy adult volunteers 91 
participated and signed a written consent after being informed of all risks and benefits of the study. One 92 
group consisted of 15 smokers (≥15 cigarettes / day; 8 men; 7 women; 36.8±9.9 years; BMI 25.6±4.1 93 
kg/m
2
) and another group consisted of 15 non-smokers (8 men; 7 women; 28.87±10.5 years; BMI 94 
23.6±3.0 kg/m
2
). Exclusion criteria included acute illness, cardiovascular diseases, intake of medication 95 
or antioxidant supplements, pregnancy and previous use of e-cigarette by smokers. For non-smokers, 96 
smoking was an additional exclusion criterion. 97 
 98 
Study Design and Procedures 99 
Participants in each group (active smokers and passive non-smokers) underwent three different 100 
experimental sessions that were performed in a random order (separated by a minimum of seven days). 101 
Participants were required to avoid food for 10 hours, strenuous physical activity for 72 hours and 102 
smoking or exposure to smoke during the night prior to the measurements. This study was part of a 103 
larger study and the procedures followed are described in detail elsewhere (Flouris et al., 2013).  104 
 105 
Active smokers 106 
Active smokers underwent a control session (ASCON), an active tobacco cigarette smoking session (ASTOB) 107 
and an active e- cigarette smoking session (ASE-CIG). Blood samples were collected prior to, immediately 108 
after, as well as one hour after the smoking sessions. During the ASCON session, participants were asked 109 
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to draw puffs on a non-lit cigarette of their own brand, for 30 minutes. In the ASTOB session participants 110 
smoked two tobacco cigarettes of their own brand within 30 minutes. During the ASE-CIG session, 111 
participants smoked a certain number of puffs on an e-cigarette (device: GIANT, NOBACCO GP, Greece) 112 
within 30 minutes. The e-cigarette liquid (NOBACCO USA MIX, NOBACCO GP, Greece) used, had tobacco 113 
taste and contained 11 mg/ml nicotine. The specific e-cigarette and liquid was selected for the study due 114 
to the fact that this liquid was the only one in Greece that had been previously analyzed by an 115 
independent publicly-funded Research  Institute and consisted of >60% propylene glycol, <10% nicotine, 116 
<5% linalool, <5% tobacco essence and <1% methyl vanilyn (Leondiadis, 2009). A previously-developed 117 
equation (Flouris et al., 2013) was used to calculate the number of e-cigarette puffs to ensure that the 118 
amount of nicotine entering the human body would be equivalent to the amount of nicotine inhaled 119 
when smoking a tobacco cigarette: [(mg of nicotine in own brand of tobacco cigarettes x 1.5 x 50)/11] x 120 
2.  121 
  122 
Passive non-smokers 123 
Non-smokers underwent a control session (PSCON), a passive tobacco cigarette smoking session (PSTOB) 124 
and a passive e-cigarette smoking session (PSE-CIG). Blood samples were collected prior to, immediately 125 
after, as well as one hour after the smoking sessions, as previously described (Flouris et al., 2013). 126 
Briefly, in the PSCON session, participants were asked to remain for 1 hour in a 60 m
3
 environmental 127 
chamber (air temperature: 21°C; air velocity: 0.05 m/sec; humidity: 45%) while breathing normal air. In 128 
the PSTOB session, participants were exposed in the same chamber for 1 hour to air polluted with 129 
tobacco cigarette smoke at a CO concentration of 23±1 ppm, that is similar to the one at bar/restaurant 130 
levels (CO90 CO-CO2 analyzer, Martindale Electric Ltd., Watford, UK). The required concentration of the 131 
gas mixture was achieved by combustion of cigarettes from several popular brands using an air pump 132 
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(DYN, Volos, Greece), which regulated the airflow at 4 L/min. Cigarettes were half smoked using the air 133 
pump, then they were left lit for 2 min to generate sidestream smoke, and then the rest of the cigarettes 134 
were smoked via the air pump. An average of 29.2±0.9 cigarettes was smoked in order to achieve the 135 
required level of CO in the exposure chamber. In the PSE-CIG session, participants were exposed to air 136 
polluted with e-cigarette vapour for one hour in the same chamber. In this case, the air was polluted by 137 
smoking e-cigarettes (device and liquid same as those used during the ASE-CIG session) via the same air 138 
pump set at an air flow rate of 4 L/min for the same time as in the PSTOB session. 139 
 140 
Blood Collection and Handling 141 
Blood samples (5 ml) were collected from each antecubital vein and were placed into EDTA-containing 142 
tubes (20 μl ETDA/ml of blood). In order to obtain plasma, samples were centrifuged immediately at 143 
1,370 x g, at 4°C for 10 min. The supernatant plasma was collected, aliquoted in Eppendorf tubes, stored 144 
at -80°C and thawed only once before analyzed for total antioxidant capacity (TAC). Red blood cells 145 
lysate was produced by diluting packed erythrocytes with distilled water (1:1 vol:vol). The mixture was 146 
inverted vigorously and centrifuged at 4,000 x g, at 4°C for 15 min. The supernatant was collected and 147 
aliquoted in Eppendorf tubes, stored at -80°C and thawed only once before analyzed for reduced 148 
glutathione (GSH) and catalase activity (CAT). Finally, in order to obtain serum, another portion of blood 149 
sample (5 ml) was collected and placed into separate tubes containing clot activator, left for 20 min to 150 
clot at room temperature, and centrifuged at 1,370 x g, at 4°C for 10 min. The supernatant was collected 151 
and aliquoted in Eppendorf tubes, stored at -80°C and thawed only once before analyzed for cotinine. 152 
 153 
Assays 154 
Page 12 of 29
URL: http://mc.manuscriptcentral.com/utxm E-mail:  TBT
Toxicology Mechanisms and Methods
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
8 
 
Procedures used to assess cotinine levels in circulating blood are described elsewhere (Flouris et al., 155 
2013). Reduced glutathione concentration was determined using previous methodology (Reddy et al., 156 
2004). Briefly, 500 μl of red blood cells lysate was treated with 500 μl TCA 5%, centrifuged at 16000 x g, 157 
at 4°C for 10 min. 300 μl of the supernatant was collected and added in 90 μl TCA 5%, centrifuged at 158 
16000 x g, at 4°C for 10 min. Thereafter, 20 μl of the TCA treated supernatant was mixed with 660 μl of 159 
67 mM sodium-potassium phosphate (pH 7.95) and 330 μl of 1 mM 5,5'-Dithiobis (2-nitrobenzoic acid) 160 
(DTNB). The samples were incubated in the dark at room temperature for 45 min and the absorbance 161 
was read at 412 nm using a spectrophotometer. The GSH concentration was calculated by standard 162 
curve constructed using commercially available standards.  163 
Catalase activity was measured according to the Aebi assay (Aebi, 1984). Briefly, 4 μl of red 164 
blood cells lysate (diluted 1:10) were added to 2,991 μl of 67 mM sodium-potassium phosphate buffer 165 
(pH 7.4) and the samples were incubated at 37°C for 10 min. The sample was transferred into a glass 166 
cuvette, 5μl of 30% hydrogen peroxide was added and the change in absorbance was immediately read 167 
at 240 nm for 90 sec.  168 
Total Antioxidant Capacity was determined according to Janaszewska & Bartosz assay 169 
(Janaszewska and Bartosz, 2002), based on the scavenging of 2,2-diphenyl-1 picrylhydrazyl (DPPH) free 170 
radical. DPPH stock solution (10mM) was prepared by dissolving 0.02g DPPH in 5ml of methanol and mix 171 
in the stirrer. The working solution was obtained by diluting stock solution 100 times with methanol. 172 
Afterwards, 20μl of plasma was mixed with 480μl of 10mM sodium-potassium phosphate (pH 7.4) and 173 
500μl of 0.1 M working solution (DPPH). The samples were incubated in the dark for 30 min at room 174 
temperature, centrifuged at 20,000 x g, at 25°C for 3 min.  900 μl of the supernatant was transferred 175 
into a clean plastic cuvette and the absorbance was read at 520 nm using a spectrophotometer. TAC is 176 
presented as mM of DPPH reduced to 2,2-diphenyl-1 picrylhydrazine (DPPH:H). 177 
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Intra-assay correlation coefficient for GSH, CAT and TAC were 3.5%, 2.8% and 2.2%, respectively.  178 
 179 
Statistical Analysis 180 
Based on data from a previously-published study (Flouris, 2009), the resulting minimum required sample 181 
size for this study was eight participants per group, providing a reliability rate of 95%. To reduce the 182 
probability of making a type II error, 15 participants were recruited for each group (smokers and non-183 
smokers). Normality was assessed by the Kolmogorov–Smirnov test and the distribution of all variables 184 
was not found significantly different from normal. A two-way (trial × time) ANOVA with repeated 185 
measures of time was used to assess differences between the three conditions in smokers and non-186 
smokers. Furthermore, a two way (condition x time) ANOVA was used to assess differences between the 187 
passive and active condition. The level of statistical significance was set at p<0.05. Data are presented as 188 
mean±SD. The SPSS version 15.0 (SPSS Inc., USA) was used for all analyses. 189 
 190 
RESULTS 191 
Active Smoking 192 
No changes were observed in GSH (Figure 2A), CAT (Figure 3A), and TAC (Figure 4A) concentrations prior 193 
to, immediately after and 1-hour after the exposure to ASTOB, ASE-CIG and ASCON (p>0.05). Furthermore, no 194 
interaction between the three conditions was revealed for any time point of assessment in any of the 195 
three variables (GSH, CAT, TAC) assessed (p>0.05). Specifically, GSH (μmol/g Hb) levels for ASTOB were 196 
2.21±0.85 prior to, 2.11±0.76 immediately after, and 1.72±0.82 one hour after the smoking sessions, 197 
respectively. During ASE-CIG, GSH levels were 2.07±1.25 prior to, 2.17±0.87 immediately after, and 198 
2.26±0.86 one hour after the smoking sessions, respectively. Finally, GSH levels for ASCON were 1.65±0.87 199 
prior to, 1.80±1.06 immediately after, and 1.92±1.28 one hour after the smoking sessions, respectively. 200 
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CAT (μmol/min/mg Hb) activity for ASTOB was 347±33 prior to, 332±14 immediately after, and 389±43 201 
one hour after the smoking sessions, respectively. Also, CAT activity for ASE-CIG was 357±14 prior to, 202 
331±55 immediately after, and 354±29 one hour after the smoking sessions, respectively. Finally, CAT 203 
activity for ASCON was 338±53 prior to, 349±66 immediately after, and 329±51 one hour after the 204 
smoking sessions, respectively. TAC (mM DPPH) levels for ASTOB were 1.03±0.09 prior to, 1.01±0.09 205 
immediately after and 0.99±0.09 one hour after the smoking sessions, respectively. During ASE-CIG, TAC 206 
levels were 0.98±0.14 prior to, 0.96±0.11 immediately after, and 0.95±0.12 one hour after the smoking 207 
sessions, respectively. Finally, TAC levels for ASCON were 1.04±0.08 prior to, 1.00±0.10 immediately after, 208 
and 1.01±0.09 one hour after the smoking sessions, respectively. 209 
 210 
Passive Smoking 211 
No time-dependent changes were found in GSH (Figure 2B), CAT (Figure 3B), and TAC (Figure 4B) 212 
concentration prior to, immediately after and one hour after the exposure to PSTOB, PSE-CIG and PSCON 213 
(p>0.05). No interaction between the three conditions was revealed for any time point of assessment in 214 
any of the three variables (GSH, CAT, TAC) assessed (p>0.05). Specifically, GSH (μmol/g Hb) levels for 215 
PSTOB were 2.08±1.02 prior to, 1.65±0.66 immediately after, and 1.53±0.81 one hour after the smoking 216 
sessions, respectively. During PSE-CIG GSH levels were 2.35±1.20 prior to, 2.65±0.81 immediately after, 217 
and 2.78±1.18 one hour after the smoking sessions, respectively. Finally, GSH levels for PSCON were 218 
1.68±0.85 prior to, 1.42±0.97 immediately after, and 1.51±0.94 one hour after the smoking sessions, 219 
respectively. CAT (μmol/min/mgHb) activity for PSTOB was 385±53 prior to, 382±45 immediately after, 220 
and 377±41 one hour after the smoking sessions, respectively. Also, CAT activity for PSE-CIG was 331±60 221 
prior to, 326±50 immediately after, and 354±72 one hour after the smoking sessions, respectively. 222 
Finally, CAT activity for PSCON was 357±90 prior to, 330±56 immediately after, and 327±60 one hour after 223 
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the smoking sessions, respectively. TAC (mM DPPH) levels for PSTOB were 1.03±0.16 prior to, 1.04±0.17 224 
immediately after and 1.02±0.16 one hour after the smoking sessions, respectively. During PSE-CIG, TAC 225 
levels were 1.03±0.16 prior to, 1.06±0.18 immediately after, and 1.04±0.13 one hour after the smoking 226 
sessions, respectively. Finally, TAC levels for PSCON were 1.00±0.18 prior to, 0.97±0.14 immediately after, 227 
and 0.99±0.17 one hour after the smoking sessions, respectively. 228 
 229 
DISCUSSION 230 
To our knowledge, this is the first study to examine the acute effects of active and passive e-cigarette 231 
smoking on the antioxidant response in human blood. The results indicate that active and passive 232 
smoking of e-cigarettes and tobacco cigarettes does not result in immediately visible perturbations of 233 
the blood antioxidant system as evaluated by GSH, CAT and TAC. 234 
 235 
Active Smoking 236 
Previous research indicates that active smoking may have detrimental effects on human health (Flouris 237 
et al., 2010). Tobacco smoking accounts for the largest amount of deaths and disability years in high-238 
income countries and is the third leading cause of death and disabilities in developing countries (Lopez 239 
et al., 2006). Tobacco contains several substances that may influence the human physiology and has 240 
been linked to oxidative stress development (Halliwell and Poulsen, 2006). Since the number of deaths is 241 
mounting and the economic burden is escalating in the recent years, new products have been 242 
introduced in the market to counteract the negative effects of smoking. Electronic cigarette is one of 243 
them and some studies indicate that cotinine levels are similar to the one found after tobacco smoking 244 
(Flouris et al., 2013). 245 
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Smoking either e-cigarettes or conventional tobacco cigarettes may disrupt human health. A 246 
recent in vitro study showed that tobacco and e-cigarette products may initiate an inflammatory 247 
response and oxidative stress production in Kupffer cells in the liver (Rubenstein et al., 2015). 248 
Furthermore, short-term e-cigarette “vaping” generates smaller changes in lung function compared to 249 
tobacco cigarette smoking (Flouris et al., 2013, Vardavas et al., 2011). However, inhaling an e-cigarette 250 
for 5 min results in attenuated exhaled nitric oxide levels (Vardavas et al., 2011, Marini et al., 2014). 251 
Changes in peripheral flow resistance due to acute narrowing of the diameter of the peripheral 252 
pathways and lower levels of nitric oxide have been proposed as possible mechanisms for the changes in  253 
exhaled nitric oxide levels following either tobacco or e-cigarette smoking (Vardavas et al., 2011). Nitric 254 
oxide, besides having an important role in several physiological processes of the respiratory tract, has 255 
been used as a marker for assessing oxidative stress (Hoyt et al., 2003). 256 
In the literature, several studies have assessed the antioxidant status of healthy smokers. 257 
According to Moriarty et al (Moriarty et al., 2003) a significant decrease in GSH levels in plasma of 258 
smokers compared to non smokers, was found. However, regarding the activities of three of the most 259 
significant antioxidant enzymes, superoxide dismutase (SOD), glutathione peroxidise (GPx) and CAT, 260 
contradictory results were found.  Another study (Zhou et al., 2000) observed decreased activity of 261 
these enzymes in erythrocytes of smokers compared to non smokers. Yildiz et al (Yildiz et al., 2002), 262 
found decreased CAT and SOD activities, however, GPx activity remained unchanged in erythrocytes of 263 
smokers compared to  non smokers, On the other hand, increased activities of these enzymes were 264 
observed in the erythrocytes of young smokers compared to age-matched non smokers (Ozguner et al., 265 
2005), reflecting that the small duration of smoking perhaps was not efficient to alter their enzymatic 266 
antioxidant response. Finally, Meta et al (Metta et al., 2015), assessed the erythrocyte antioxidant 267 
defense against cigarette smoking, finding that there was highly significant difference in SOD activity, in 268 
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comparison to CAT and GPx between smokers and non smokers. Indeed, while CAT and GPx activities 269 
were found decreased, SOD activity was found increased in smokers compared to non smokers. TAC was 270 
also assessed in blood of smokers and non smokers and was found unchanged in the study of Kurku et al 271 
(Kurku et al., 2015) and decreased in smokers in the study of Mojtaba et al (Mojtaba et al., 2014) 272 
In the study of Kurku et al (Kurku et al., 2015) acute effects of smoking on antioxidant defense 273 
were also assessed. Specifically, saliva samples were collected from smokers 1 h after smoking only one 274 
cigarette. Nevertheless, no difference in the levels of TAC, SOD and GPx was observed pre and before 275 
smoking. The short period of exposure to only one cigarette, was not enough to cause antioxidant 276 
defense modifications. The aforementioned attenuation of exhaled nitric oxide levels following active e-277 
cigarette and tobacco cigarette smoking may suggest changes in redox status. However, we did not 278 
observe any statistically significant acute changes in antioxidant levels either in time or between groups. 279 
We scrutinized our data further by examining our data as percentage of initial value, to account for 280 
subject variability (data not shown) without again finding statistically significant alterations in 281 
antioxidant levels. Perhaps the oxidative stress does not stem from a reduction in antioxidant capacity 282 
but from an increase in oxidants. Moreover, the tissue assessed may play a role. In this study we 283 
assessed changes in the antioxidant system in blood and red blood cells lysate (to systemic oxidative 284 
status) whereas the exhaled nitric oxide levels assessed in previous studies indicates airway oxidative 285 
stress. Additionally, we restricted our study to the immediate effects of smoking on antioxidant levels. 286 
Therefore, we cannot exclude that reductions in antioxidant capacity could be revealed if sampling was 287 
repeated some hours after the exposure. Further studies are needed to elucidate possible differences in 288 
the redox response between tissues, especially following active e-cigarette smoking. 289 
 290 
Passive Smoking 291 
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Chronic exposure to passive tobacco smoking has been shown to generate unfavourable health effects 292 
(Faught et al., 2009, Carrillo et al., 2009) since it increases the risk of heart disease by approximately 293 
30% whereas acute exposure (minutes to hours) has nearly as large effects as chronic active smoking 294 
(Metsios et al., 2007, Dinas et al., 2011, Barnoya and Glantz, 2005). The negative health effects of 295 
tobacco passive smoking are exemplified by acute unfavorable effects on lung function, cytokine 296 
production, thyroid hormone secretion, and complete blood count parameters (Dinas et al., 2014, 297 
Flouris et al., 2008, Metsios et al., 2007). Chronic exposure to passive tobacco smoking has been also 298 
shown to result in changes in redox balance. Exposure to chronic passive smoking results in a 63% 299 
increase in 8-hydroxy-2'-deoxyguanosine in the blood of exposed subjects and 13% and 37% increase in 300 
catalase and glutathione peroxidase activity, respectively (Howard et al., 1998). Furthermore, a strong 301 
association between serum protein carbonyl and malondialdehyde concentration has been revealed in 302 
non-smoker patients hospitalized for acute myocardial infarction (Megson et al., 2013). Yildiz et al (Yildiz 303 
et al., 2002), evaluated the erythrocyte antioxidant defence of passive smokers and found significantly 304 
decreased CAT and SOD activities in passive smokers in comparison to non smokers.  Based on these 305 
findings, it is clear that exposure of chronic passive tobacco smoking can lead to changes in redox status. 306 
However, there is only a limited number of interventional studies that assessed oxidative stress 307 
responses following a single exposure to passive smoking. These studies indicate that acute passive 308 
tobacco smoking results in airway acidification, oxidative stress, and decreased levels of FeNO (Flouris et 309 
al., 2013, Kostikas et al., 2013). Furthermore, significant increases have been reported in 8-isoprostane 310 
levels after 30 min of passive smoking, an increase that was equivalently to the levels of smokers (Kato 311 
et al., 2006). These results are in contrast with the current findings of no changes in redox status 312 
markers neither immediately post nor 1-hour post exposure. Possible reasons for this contradiction 313 
might be that we assessed components of the antioxidant system whereas the previous studies assessed 314 
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markers of oxidative stress. Furthermore, two of the three aforementioned studies assessed oxidative 315 
stress in lungs. We assessed systemic oxidative stress in molecules found in the blood which may not 316 
reflect lung tissue levels, or may require some time before any changes are observed. 317 
Acute exposure to passive e-cigarette environments has been shown to increase cotinine levels 318 
to an extent similar to that of passive tobacco cigarette smoking (Flouris et al., 2013). However, passive 319 
e-cigarette vapour exposure shows no significant changes in lung function (Flouris et al., 2013). 320 
Furthermore, passive e-cigarette vapour exposure does not appear to influence the results of the 321 
complete blood count examination (Flouris et al., 2012). The present results indicate that a 1-hour 322 
exposure to a passive e-cigarette environment does not cause significant perturbations in the 323 
antioxidant system up to 1-hour post-exposure. It is possible that changes would become evident if we 324 
had continued our observation for a longer period. Finally, as our measurements indicate systemic redox 325 
status, we cannot exclude alterations at the level of the lung epithelial cells, as observed in a mouse 326 
study (Lerner et al., 2015). 327 
It is important to note that, while we instructed our subjects to consume similar meals in the 328 
day prior to each assessment, we did not strictly monitor their diet. High levels of food and/or high 329 
activity of other endogenous antioxidants may explain the lack of responses in the antioxidant system 330 
following the active or passive smoking procedures. This is because the bioavailability of the antioxidant 331 
vitamin C changes following smoking whereas its turnover in smokers is 40% higher compared to non-332 
smokers (German Nutrition, 2015). 333 
 334 
CONCLUSION 335 
 In conclusion, we found that tobacco and e-cigarette smoking exposure do not acutely alter the 336 
response of the antioxidant system, neither under active nor passive smoking conditions. Overall, there 337 
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is not distinction between tobacco and e-cigarette active and passive smoking effects on specific redox 338 
status indices.  339 
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Figure 2. Glutathione (GSH) levels (mean±SD) following active (A) and passive smoking (B). 464 
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Figure 3 Catalase activity (mean±SD) following active (A) and passive smoking (B). 466 
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